PMID- 35993661
OWN - NLM
STAT- MEDLINE
DCOM- 20220823
LR  - 20221214
IS  - 2284-0729 (Electronic)
IS  - 1128-3602 (Linking)
VI  - 26
IP  - 15
DP  - 2022 Aug
TI  - Hyperbaric oxygen therapy as a supportive therapy for COVID-19 patients: a 
      narrative review.
PG  - 5618-5623
LID - 29435 [pii]
LID - 10.26355/eurrev_202208_29435 [doi]
AB  - The Coronavirus illness 2019 (COVID-19) was first observed to induce fever, dry 
      cough, pneumonia, and dyspnea in the lower respiratory tract. Atypical 
      manifestations, including digestive problems and cardiac symptoms, were also 
      observed. The rate of mortality in the older population is greater than in the 
      younger group, as well as in individuals suffering from comorbidities. Oxygen 
      supplementation through a facemask, non-invasive ventilation, mechanical 
      ventilation, and extracorporeal membrane oxygenation ECMO are some of the 
      available supportive techniques. Hyperbaric oxygen treatment (HBOT) is thought to 
      boost tissue oxygenation by increasing plasma soluble oxygen levels. HBOT also 
      reduces inflammatory responses in COVID-19 patients, minimizing the negative 
      impacts of the cytokine storm. Because the existing data on the efficacy of HBOT 
      in COVID-19 patients is limited, the purpose of this article is to review the 
      possible mechanisms of HBO, as well as data available on potential advantages, 
      side effects and uses in the treatment of COVID-19 patients.
FAU - Allam, N M
AU  - Allam NM
AD  - Department of Physical Therapy and Health Rehabilitation, College of Applied 
      Medical Science, Jouf University, Jouf, Saudi Arabia. hd_mos@yahoo.com.
FAU - Eladl, H M
AU  - Eladl HM
FAU - Eid, M M
AU  - Eid MM
LA  - eng
PT  - Journal Article
PT  - Review
PL  - Italy
TA  - Eur Rev Med Pharmacol Sci
JT  - European review for medical and pharmacological sciences
JID - 9717360
RN  - S88TT14065 (Oxygen)
SB  - IM
MH  - *COVID-19/therapy
MH  - Humans
MH  - *Hyperbaric Oxygenation/methods
MH  - Oxygen
MH  - *Pneumonia
MH  - Respiration, Artificial
MH  - SARS-CoV-2
EDAT- 2022/08/23 06:00
MHDA- 2022/08/24 06:00
CRDT- 2022/08/22 08:42
PHST- 2022/08/22 08:42 [entrez]
PHST- 2022/08/23 06:00 [pubmed]
PHST- 2022/08/24 06:00 [medline]
AID - 29435 [pii]
AID - 10.26355/eurrev_202208_29435 [doi]
PST - ppublish
SO  - Eur Rev Med Pharmacol Sci. 2022 Aug;26(15):5618-5623. doi: 
      10.26355/eurrev_202208_29435.